Sign in

Alain Amstutz | Ts'epo

@alainamstutz.bsky.social
76 followers 261 following 1 posts

MD PhD | Trying to bridge the gap between trialist and epidemiologist | Jazz piano enthusiast | Keen on understanding Alkebulan History

PostsRepliesMedia
Reposted by Alain Amstutz | Ts'epo
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 08/07/2025
💇🏾‍♀️ New publication from our team: Hair Salons as a promising space to provide HIV & Sexual and SRH services for young women in Lesotho 💭 The team is currently looking for funding to implement a pilot - ideas welcome! Read more here: bmcpublichealth.biomedcentral.com/articles/10....
bmcpublichealth.biomedcentral.com
Hair salons as a promising space to provide HIV and sexual and reproductive health services for young women in Lesotho: a citizen scientist mixed-methods study - BMC Public Health
Introduction Adolescent girls and young women in southern Africa are disproportionately affected by HIV and sexual and reproductive health (SRH) challenges. There is a need for more accessible and de-...
053
Reposted by Alain Amstutz | Ts'epo
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 15/05/2025
With over 96% of global trial data on this topic included, this #IPDMA, published in @lancetrespirmed.bsky.social and initiated by #EU-RESPONSE, provides the most comprehensive analysis for JAK inhibitors for adults hospitalized due to #COVID19. Full article: www.thelancet.com/journals/lan...
thelancet.com
Effects of Janus kinase inhibitors in adults admitted to hospital due to COVID-19: a systematic review and individual participant data meta-analysis of randomised clinical trials
This IPDMA of RCTs in adults admitted to hospital due to COVID-19 found that JAK inhibitors reduced mortality across all levels of respiratory support, independent of dexamethasone or tocilizumab, and...
144
Reposted by Alain Amstutz | Ts'epo
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 14/05/2025
📰 New Article: Effects of Janus kinase inhibitors in adults admitted to hospital with #COVID19: a systematic review and IPD meta-analysis of randomised clinical trials Findings suggested that JAK inhibitors reduced mortality across all levels of respiratory support 🔗 tinyurl.com/2hprv99v
Research in context panel:

"Our IPDMA presents the most comprehensive summary of all existing randomised evidence (including >96% of participants recruited globally on the topic) and subgroup analyses settling the issue of discordant guidelines. JAK inhibitors seem a safe and efficacious treatment option for adults hospitalised with COVID-19 when given in addition to usual care."
157
Reposted by Alain Amstutz | Ts'epo
Philippa Matthews @pippa-matt.bsky.social · 23/04/2025
"Get the experts into the room, and get a plan together...We don’t need perfection, but we do need urgency. The health system that is delivering HIV care is unravelling now. The cost of doing nothing is millions of lives and a shattered legacy." @francoisventer.bsky.social
groundup.org.za
Our HIV programme is collapsing — and our government is nowhere to be seen
But urgent action can save us
056
Alain Amstutz | Ts'epo @alainamstutz.bsky.social · 23/03/2025
Causal understanding is not a point of view, it’s a point of do - what a beautifully written essay by @marielgoddu.bsky.social: aeon.co/essays/causa...
aeon.co
Causal understanding is not a point of view, it’s a point of do | Aeon Essays
Humans have a superpower that makes us uniquely capable of controlling the world: our ability to understand cause and effect
020
Reposted by Alain Amstutz | Ts'epo
Queen Mary University of London @qmul.bsky.social · 31/01/2025
Delighted to see Prof @profchloeorkin.bsky.social, Director @shareeastlondon.bsky.social & Consultant HIV physician at Barts Health, profiled in @thelancet.bsky.social today. Great to learn more about her career, with ‘equality at its heart, motivated by activism’ www.thelancet.com/journals/lan...
thelancet.com
Chloe Orkin: forefronting social justice in medicine
HIV researcher and physician Chloe Orkin, Professor of Infection and Inequities at Queen Mary University of London, UK, embarked on her career at the age of just 16 years when she began her medical de...
0187
Reposted by Alain Amstutz | Ts'epo
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 31/01/2025
Data sharing is a big hurdle in Individual Participant Data Mata Analysis (#IPDMA). Matthias Briel and @alainamstutz.bsky.social participated at a EOSC-ENTRUST workshop to address this problem. More: ecrin.org/news/eosc-en... @ecrin.bsky.social #UniversityofOslo #HealthDataResearchUK
041
Reposted by Alain Amstutz | Ts'epo
Marion Campbell @marionkcampbell.bsky.social · 27/01/2025
An issue that often comes up is how to set a “non-inferiority margin” in a non-inferiority trial and how to ensure it is appropriate 1/8 #MethodologyMonday #109
23522